Alendronate Sodium Tablets
CAS: 121268-17-5
Molecular Formula: C4H12NNaO7P2·3H2O
Molecular Weight: 325.12
Product description:Is the world's most widely used osteoporosis drug resistance, is listed in the United States in 1993, significantly increased in patients with bone mineral density, to reduce the risk of fractures, osteoporosis is first-line treatment drugs. Allen phosphonic acid sodium amino phosphonic acid salt of bone resorption inhibitor, and bone hydroxyapatite has a strong affinity, can enter the bone matrix hydroxyapatite crystal, when osteoclast dissolved crystals, the drug is released, can inhibit osteoclast activity, and inhibiting bone resorption by osteoblasts indirect effect, has a strong resistance to bone resorption activity, no bone mineralization characteristics of inhibition.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: